Subscribe to RSS
DOI: 10.1055/a-1532-4576
Elevated Serum Levels of Carbohydrate Antigen 72–4 in Diabetic Kidney Disease
Supported by: National Natural Science Foundation of China 82074185
Abstract
The aim of this study was to determine whether carbohydrate antigen 72–4 (CA72–4) is elevated in diabetic kidney disease (DKD), and examine the association between urinary albumin-to-creatinine ratio (UACR) and CA72–4 in patients with type 2 diabetes mellitus (T2DM). Non-dialysis patients with T2DM (n=296) and 90 healthy controls were recruited in this study. CA72–4 level was measured by electrochemiluminescence immunoassay. DKD was defined as UACR≥ 30 mg/g in the absence of a urinary infection or other renal diseases. We found that patients with DKD had significantly higher serum CA72–4 levels compared to those with normoalbuminuria and healthy controls. Positive rates of CA72–4 increased gradually and markedly from normoalbuminuria to microalbuminuria and to macroalbuminuria in diabetic patients (7.5, 11.2, and 17.4%, respectively; P for trend< 0.05). CA72–4 also showed a positive correlation with UACR (r=0.288, P< 0.01). Logistic regression analysis revealed the association of increased UACR with an increased odds ratio of elevation of CA72–4 levels (P for trend< 0.05) after multivariable adjustment. In conclusion, serum levels of CA72–4 increase abnormally with the increase in urinary albumin excretion, which affects the specificity of diagnosis of malignancies. An appropriate interpretation of CA72–4 is essential to prevent unnecessary and even hazardous diagnostic procedures in patients with T2DM.
Publication History
Received: 02 February 2021
Received: 05 June 2021
Accepted: 15 June 2021
Article published online:
04 October 2021
© 2021. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Li Y, Teng D, Shi X. et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study. BMJ 2020; 369: m997 DOI: 10.1136/bmj.m997.
- 2 Chen C, Chen Q, Nie B. et al. Trends in bone mineral density, osteoporosis, and osteopenia among U.S. adults with prediabetes, 2005-2014. Diabetes Care 2020; 43: 1008-1015 DOI: 10.2337/dc19-1807.
- 3 Noto H, Goto A, Tsujimoto T. et al. Latest insights into the risk of cancer in diabetes. J Diabetes Investig 2013; 4: 225-232 DOI: 10.1111/jdi.12068.
- 4 Qi J, He P, Yao H. et al. Cancer risk among patients with type 2 diabetes: A real-world study in Shanghai, China. J Diabetes 2019; 11: 878-883 DOI: 10.1111/1753-0407.12926.
- 5 Giovannucci E, Harlan DM, Archer MC. et al. Diabetes and cancer: A consensus report. Diabetes Care 2010; 33: 1674-1685 DOI: 10.2337/dc10-0666.
- 6 Colcher D, Hand PH, Nuti M. et al. A spectrum of monoclonal antibodies reactive with human mammary tumor cells. Proc Natl Acad Sci USA 1981; 78: 3199-3203 DOI: 10.1073/pnas.78.5.3199.
- 7 Wang SL, Yu GY, Yao J. et al. Diagnostic role of carbohydrate antigen 72-4 for gastrointestinal malignancy screening in Chinese patients: A prospective study. J Dig Dis 2018; 19: 685-692 DOI: 10.1111/1751-2980.12681.
- 8 Hu PJ, Chen MY, Wu MS. et al. Clinical evaluation of CA72-4 for screening gastric cancer in a healthy population: a multicenter retrospective study. Cancers (Basel) 2019; 11. DOI:10.3390/cancers11050733
- 9 Mariampillai AI, Cruz JPD, Suh J. et al. Cancer antigen 72-4 for the monitoring of advanced tumors of the gastrointestinal tract, lung, breast and ovaries. Anticancer Res 2017; 37: 3649-3656 DOI: 10.21873/anticanres.11735.
- 10 Bai X, Sun M, He Y. et al. Serum CA72-4 is specifically elevated in gout patients and predicts flares. Rheumatology (Oxford) 2020; 59: 2872-2880 DOI: 10.1093/rheumatology/keaa046.
- 11 Gross JL, de Azevedo MJ, Silveiro SP. et al. Diabetic nephropathy: Diagnosis, prevention, and treatment. Diabetes Care 2005; 28: 164-176 DOI: 10.2337/diacare.28.1.164.
- 12 Gupta R, Misra A. Epidemiology of microvascular complications of diabetes in South Asians and comparison with other ethnicities. J Diabetes 2016; 8: 470-482 DOI: 10.1111/1753-0407.12378.
- 13 Molitch ME, DeFronzo RA, Franz MJ. et al. Diabetic nephropathy. Diabetes Care 2003; 26: S94-S98 DOI: 10.2337/diacare.26.2007.s94.
- 14 Shang X, Song C, Du X. et al. The serum levels of tumor marker CA19-9, CEA, CA72-4, and NSE in type 2 diabetes without malignancy and the relations to the metabolic control. Saudi Med J 2017; 38: 204-208 DOI: 10.15537/smj.2017.2.15649.
- 15 Chen C, Zhao L, Ning Z. et al. Famine exposure in early life is associated with visceral adipose dysfunction in adult females. Eur J Nutr 2019; 58: 1625-1633 DOI: 10.1007/s00394-018-1707-0.
- 16 Chen C, Xu H, Chen Y. et al. Iodized salt intake and its association with urinary iodine, thyroid peroxidase antibodies, and thyroglobulin antibodies among urban Chinese. Thyroid 2017; 27: 1566-1573 DOI: 10.1089/thy.2017.0385.
- 17 Chen C, Zhai H, Cheng J. et al. Causal link between vitamin D and total testosterone in men: A Mendelian randomization analysis. J Clin Endocrinol Metab 2019; 104: 3148-3156 DOI: 10.1210/jc.2018-01874.
- 18 Lv X, Sun W, Huang X. et al. Association of serum fetuin-A levels with the risk of albuminuria in middle-aged and elderly Chinese. J Clin Endocrinol Metab 2016; 101: 1235-1242 DOI: 10.1210/jc.2015-2599.
- 19 Wu J, Li X, Tao Y. et al. Free triiodothyronine levels are associated with diabetic nephropathy in euthyroid patients with type 2 diabetes. Int J Endocrinol 2015; 2015: 204893 DOI: 10.1155/2015/204893.
- 20 Demirci H, Erdamar H, Karakoc A. et al. CA 72-4 levels in patients with type 2 diabetes mellitus. Int J Clin Pract 2010; 64: 34-38 DOI: 10.1111/j.1742-1241.2007.01614.x.
- 21 Liu D, Xu M, Ding LH. et al. Activation of the Nlrp3 inflammasome by mitochondrial reactive oxygen species: A novel mechanism of albumin-induced tubulointerstitial inflammation. Int J Biochem Cell Biol 2014; 57: 7-19 DOI: 10.1016/j.biocel.2014.09.018.
- 22 Zhuang Y, Yasinta M, Hu C. et al. Mitochondrial dysfunction confers albumin-induced NLRP3 inflammasome activation and renal tubular injury. Am J Physiol Renal Physiol 2015; 308: F857-F866 DOI: 10.1152/ajprenal.00203.2014.
- 23 Jheng HF, Tsai PJ, Chuang YL. et al. Albumin stimulates renal tubular inflammation through an HSP70-TLR4 axis in mice with early diabetic nephropathy. Dis Model Mech 2015; 8: 1311-1321 DOI: 10.1242/dmm.019398.
- 24 Inker LA, Coresh J, Levey AS. et al. Estimated GFR, albuminuria, and complications of chronic kidney disease. J Am Soc Nephrol 2011; 22: 2322-2331 DOI: 10.1681/asn.2010111181.
- 25 Klammt S, Wojak HJ, Mitzner A. et al. Albumin-binding capacity (ABiC) is reduced in patients with chronic kidney disease along with an accumulation of protein-bound uraemic toxins. Nephrol Dial Transplant 2012; 27: 2377-2383 DOI: 10.1093/ndt/gfr616.
- 26 Narita T, Sasaki H, Hosoba M. et al. Parallel increase in urinary excretion rates of immunoglobulin G, ceruloplasmin, transferrin, and orosomucoid in normoalbuminuric type 2 diabetic patients. Diabetes Care 2004; 27: 1176-1181 DOI: 10.2337/diacare.27.5.1176.
- 27 Gluhovschi C, Gluhovschi G, Petrica L. et al. Urinary biomarkers in the assessment of early diabetic nephropathy. J Diabetes Res 2016; 2016: 4626125 DOI: 10.1155/2016/4626125.
- 28 Chen C, Wang C, Hu C. et al. Normoalbuminuric diabetic kidney disease. Front Med 2017; 11: 310-318 DOI: 10.1007/s11684-017-0542-7.
- 29 Ali MK, Bullard KM, Saydah S. et al. Cardiovascular and renal burdens of prediabetes in the USA: Analysis of data from serial cross-sectional surveys, 1988-2014. Lancet Diabetes Endocrinol 2018; 6: 392-403 DOI: 10.1016/s2213-8587(18)30027-5.